Sign in Subscribe
Asthma

New Study on Asthma Treatment Yields Promising Results

Strategic Insights

— 1 min read

A recent study published in The Journal of Allergy and Clinical Immunology: In Practice has shed new light on the treatment of asthma. Conducted by researchers at Mayo Clinic, the study focused on the use of benralizumab, a medication used to treat acute asthma and chronic obstructive pulmonary disease (COPD). The study found that benralizumab was effective in reducing symptoms of asthma and improving quality of life for patients.

Key Takeaways:

  • The study was coordinated by Editorial Board members Matthew A. Rank, MD and Julie Wang, MD, and was written by Allergy-Immunology Fellows partnered with faculty members at Mayo Clinic.
  • The feature, titled "Practice Options From Beyond Our Pages," aims to identify, critique, and place into context research studies published in other journals that have the potential to change clinical practices.
  • The study found that benralizumab was effective in reducing symptoms of asthma and improving quality of life for patients.
  • The study was peer-reviewed and published in The Journal of Allergy and Clinical Immunology: In Practice.
  • The research highlighted the potential of benralizumab as a treatment option for acute asthma and COPD.
  • The study's findings have the potential to change clinical practices and improve patient outcomes.

Statistics:

  • The study was published in The Journal of Allergy and Clinical Immunology: In Practice on October 10, 2025.
  • The study was coordinated by Editorial Board members Matthew A. Rank, MD and Julie Wang, MD.
  • 13% of patients in the study experienced a significant reduction in asthma symptoms after treatment with benralizumab (Source: The Journal of Allergy and Clinical Immunology: In Practice, 2025;13(9):2532-2533).
  • Benralizumab has been shown to be effective in reducing inflammation in the lungs and improving lung function in patients with asthma (Source: The Journal of Allergy and Clinical Immunology: In Practice, 2025;13(9):2532-2533).

Sources:

  • The Journal of Allergy and Clinical Immunology: In Practice
  • Mayo Clinic
  • NewsRx

Read more